東南亞生技藥品市場

東南亞生技藥品市場 是由出版商Espicom Business Intelligence在2008年07月所出版的。 這份英文市場調查報告書包含Pages: 204 價格從美金1390起跳。

簡介

目錄

Often overshadowed by commercial interest in China and India, the countries of SE Asia offer both a growing market for biopharmaceuticals and a research-driven environment for their development.

The worldwide market for biotechnology pharmaceuticals was valued by Espicom at an estimated US$80 billion in 2007, representing 9.6% of the total global pharmaceutical sales (prescription and OTC), which stood at approximately US$830 billion. In 2007, reported sales of 40 of the leading biopharmaceuticals sold by the major western manufacturers totalled US$71.6 billion, having risen by 13.7% over the previous year.

This detailed report analyses the market and research environments, assessing risk and identifying opportunity in Indonesia, Malaysia, Singapore, South Korea, Taiwan and Thailand.

• A thorough review of the burgeoning market for biopharmaceutical drugs in SE Asia
• An examination of the markets in terms of investment and research opportunities
• Market forecasts to 2013 for biopharmaceuticals
• A review of over 65 local companies/ organisations developing biopharmaceutical products

• Indonesia
• Malaysia
• Singapore
• South Korea
• Taiwan
• Thailand

• FOREWORD
• OVERVIEW
  • The Global Market for Biotechnology Pharmaceuticals
    • Biotechnology Pharmaceuticals in the Global Market, 2007
    • Leading Biopharmaceuticals by Revenue, 2007 (US$ million)
    • Leading Biopharmaceuticals Ranked by US$ Revenue Growth, 2006/2007 million)
    • Global Pharmaceutical Sales by Region, 2008
    • Estimated Global Biopharmaceutical Sales by Region, 2008
    • Estimated South East Asian Biopharmaceutical Sales, 2008
    • Estimated South East Asian Biopharmaceutical Sales, 2008
    • Projected South East Asian Biopharmaceutical Sales, 2008-2013
    • Case Study: India" s Biopharmaceutical Market, 2002
  • South East Asia - Pharmaceutical Market Data
    • South East Asian Pharmaceutical Market, 2008-13 (US$ Millions)
    • South East Asian Pharmaceutical Market Per Capita, 2008-13 (US$)*
    • South East Asian Pharmaceutical Market AAGR, 2008-13 (%)
  • South East Asia - Demographic Data
    • South East Asian Population*, 2008-13 (Millions)
    • South East Asian Population Growth*, 2008-13 (%)
    • South East Asian Population*, Number Aged 65+, 2008-13 (Millions)
    • South East Asian Population*, % Aged 65+, 2008-13
  • South East Asia - Economic Data
    • South East Asian GDP*, 2008-13 (US$ Billions)
    • South East Asian GDP Per Capita*, 2008-13 (US$)
    • South East Asian Real GDP Growth*, 2008-13 (%)
  • South East Asia - Healthcare Expenditure
    • South East Asian Health Expenditure*, 2008-13 (US$ Billions)
    • South East Asian Health Expenditure Per Capita*, 2008-13 (US$)
    • South East Asian Health Expenditure as % of GDP*, 2008-13
  • South East Asia - Pharmaceutical Trade
    • South East Asian Pharmaceutical Imports, 2001-06 (US$000s)
    • South East Asian Pharmaceutical Exports, 2001-06 (US$000s)
• BIOTECHNOLOGY IN SOUTH EAST ASIA
  • Selection of Biotechnology as a Key Strategic Area
• BIOPHARMACEUTICALS IN SOUTH EAST ASIA
• Biosimilars
  • Rapidly growing markets
  • Significant untapped demand
  • Less competition from originators
  • Greater acceptance from users
  • Regulatory barriers are likely to be lower
• INDONESIA
  • Biopharmaceutical Market
    • Indonesia - Projected Biopharmaceutical Market 2008-2013 (US$ million)
  • Pharmaceutical Market
    • Summary of the Indonesian Pharmaceutical Market in 2008
    • Projected Pharmaceutical Market, 2008-2013
  • Market Environment
  • Government Biotechnology Initiatives
  • Biopharmaceutical Research Agencies
    • Indonesian Institute of Sciences (Lembaga Ilmu Pengetahuan Indonesia - LIPI)
    • Indonesian Biotechnology Consortium
    • Galang Island
    • Biopharmaceutical Manufacturing
    • PT Bio Farma
      • Partnerships
    • Kalbe Farma Biotek
      • Financials
    • Kimia Farma
      • Agreements
        • LIPI
        • Fraunhofer Institute
        • Financials
• KOREA
  • Biotechnology Market
    • Korean Biotechnology Market 1994-2005
  • Government Biotechnology Initiatives
    • Korean Government Investment in Biotechnology R&D 1994-2006 (KRW billion)
    • Korea" s 2007-2016 Biotechnology Development Strategy
    • Korea" s 2006-2015 Biotechnology Development Strategy Targets (US$ billion)
  • Investment
    • Planned Investment in Korean Biotechnology 2007-2016
  • Employment
  • Biopharmaceutical Market
    • Korea - Projected Biopharmaceutical Market 2008-2013 (US$ million)
  • Pharmaceutical Market
    • Summary of the Korean Pharmaceutical Market in 2008
    • Projected Pharmaceutical Market, 2008-2013
  • Market Environment
  • Manufacturing & Research
    • Bukwang Pharma
      • Financials
        • Bukwang Pharmaceutical - Key Financial Data 2004-2006* (KRW billion)
    • Chemizon
      • Agreements
        • Korean Research Institute of Bioscience and Biotechnology (KRIBB)
        • Crown Bioscience
        • Takeda
        • Array BioPharma
    • Chong Kun Dang Bio
      • Agreements
      • Financials
    • Choongwae Pharma
    • CJ CheilJedang
      • Agreements
      • Neuralstem
  • Daewoong Pharma
    • Research
      • Daewoong Pharma - Biopharmaceutical Pipeline
    • Financials
      • Daewoong Pharma - Key Financial Data 2005-2007* (KRW billion)
  • Dong-A Pharma
    • Biopharmaceutical Product Portfolio
      • Dong-A Pharmaceutical - Biopharmaceutical Product Portfolio
      • Dong-A Pharmaceutical Export Plan for Biopharmaceuticals
    • Research
      • Dong-A Pharmaceutical - R&D Pipeline
    • DA-3031
    • HB-110
    • 2008 Plans
  • Agreements
    • Ukraine
  • Financials
    • Dong-A Pharmaceutical - Key Financial Data 2005-2007* (KRW billion)
    • Dong-A Pharmaceutical - % of Revenues by Region, 2007 & 2012*
    • Dong-A Pharmaceutical - Biopharmaceutical Revenues, 2007* (KRW billion)
  • Green Cross
    • Product Portfolio
      • Blood Derivatives
      • Vaccines
    • R&D Pipeline
      • Green Cross - R&D Pipeline
    • Mogam Biotechnology Research Institute
      • Financials
    • Korea Stem Cell Bank
    • Kuhnil Pharmaceutical Company
    • Agreements
      • YM BioSciences
      • Viragen
  • LG Life Sciences
    • LG Life Sciences - Product Portfolio
  • Financial Overview
    • LG Life Sciences - Key Financial Data 2004-2006 (billion won)
    • LG Life Sciences - Revenue by Segment, 2006
  • Sewon Cellontech
    • Agreements
      • UCLB & RNOH
  • SK Chemicals Life Science
  • Yuhan Pharmaceuticals
• MALAYSIA
  • Biopharmaceutical Market
    • Malaysia - Projected Biopharmaceutical Market 2008-2013 (US$ million)
  • Pharmaceutical Market
    • Summary of the Malaysian Pharmaceutical Market in 2008
    • Projected Pharmaceutical Market, 2008-2013
  • Market Environment
  • Government Biotechnology Initiatives
    • Phase I - 2006-2010 "Capacity Building"
    • Phase II - 2011-2015 "Science to Business"
    • Phase III - 2016-2020 "Global Presence"
    • NBP Focus Areas
    • Creation of BioNexus
    • Tax Incentives
    • Eighth National Plan 2001-2005
      • Human Resource Development
      • Research and Development
      • Infrastructure and Facilities
      • Regulatory Framework
      • Public R&D Biotechnology Projects, 2001-2005
    • Private Sector Participation
      • Approved Biotechnology Manufacturing Projects, 2001-2005 (RM Million)
  • Ninth National Plan 2006-2010
    • Biotechnology Development
    • Building a Malaysian Brand
    • Regulatory Framework
    • Financial Infrastructure
    • Human Capital Development
    • R&D and Technology Acquisition
    • Institutional Support and Allocation
      • Development Expenditure and Allocation for Biotechnology, 2001-2010 (RM million)
  • Ministry of Science & Technology/BIOTEK
  • Malaysian Biotechnology Corporation (BiotechCorp)
  • Malaysian Bio-industry Organisation
  • Incubators
  • Manufacturing & Research
    • Actis Biologics
      • Actis Biologics - Pipeline
    • Alpha Biologics
    • Autoimmune Sdn Bhd
    • BioFact Life Sdn Bhd
    • Bio Molecular Industries Sdn Bhd
    • Bioven
      • EGF Cancer Vaccine
    • Biovic Sdn Bhd
    • CCM Duopharma Biotech
      • Financials
    • Inno Biologics
      • Agreements
        • GE Healthcare
    • InQpharm Asia
  • KL Biotech Manufacturing Sdn Bhd
  • StemLife Berhad
  • Stempeutics Research Malaysia Sdn Bhd
  • Synamatix
    • Agreements
      • Universiti Malaysia Sabah Biotechnology Research Institute
      • Emory University School of Medicine
      • 454 Life Sciences
    • Malaysian Genomics Resources Centre
  • Vivantis Technologies Sdn Bhd (lab services)
• SINGAPORE
  • Biotechnology Market Overview
    • Investment
      • Investment Commitments in Biomedical Manufacturing
  • Biopharmaceutical Market
    • Singapore - Projected Biopharmaceutical Market 2008-2013 (US$ million)
  • Pharmaceutical Market
    • Summary of the Singapore Pharmaceutical Market, 2008
    • Market Projections, 2008-2013
  • Market Environment
  • Government Biotechnology Initiatives
    • Biomedical Sciences Initiative
    • Singapore Economic Development Board
  • A*STAR
  • Biomedical Research Council (BMRC)
  • Biopolis
  • Bio*One Capital
    • Bio*One Capital Investment Funds
      • Singapore Bio-Innovations (SBI)
      • PharmBio Growth Fund/Life Sciences Investment Fund (PGF/LSI)
      • Biomedical Sciences Investment Fund (BMSIF)
      • BMS INC (Innovate ‘N' Create)
  • Manufacturing & Research - Multinational Investments
    • Genentech
    • GlaxoSmithKline
    • Lonza
    • Schering-Plough
  • Manufacturing & Research - Domestic
    • 1st BASE
    • A-Bio Pharma
      • Agreements
        • Artisan Pharma
        • GSK Biologicals
    • AMRI Singapore
      • Agreements
        • Achaogen
        • Cystic Fibrosis Foundation
      • Financials
    • CellResearchCorp
    • Chakra Biotech Sdn Bhd
      • Chakragati Mouse
      • Novel Compounds
      • Agreements
        • Tikvah Therapeutics
        • University at Buffalo
    • ES Cell International
      • Agreements
        • Curis
        • Ortec International
        • Quark Biotech
    • Experimental Therapeutics Centre
    • i-DNA Biotechnology
    • Innogene Kalbiotech
      • Innogene Kalbio - Product Portfolio
      • Innogene Kalbiotech - Biopharmaceutical R&D Portfolio
  • LYNK Biotechnologies
    • MediLynk
    • Financials
  • Maccine
    • Agreements
  • MerLion
    • Agreements
      • Astellas Pharma
      • Banyu Pharmaceutical
      • National Cancer Institute
      • National Parks Board of Singapore
      • Novartis Institute for Tropical Diseases
    • Financials
  • Moleac
  • S*BIO
    • Research & Development
      • Clinical Trials
    • HDAC
    • Kinase Programme
      • S*BIO R&D Pipeline, 2008
    • Agreements
      • Genome Institute of Singapore
      • Karolinska Institutet
  • SciGen
    • Product Portfolio
    • Pipeline Products
    • Financials
      • SciGen Revenues by Geographic Breakdown, 2007
  • SingVax
    • Agreements
      • Crucell
      • OctoPlus
• TAIWAN
  • Biotechnology Market Overview
    • Current Status of Biotechnology Development in Taiwan - 2005
  • Biopharmaceutical Market
    • Taiwan - Projected Biopharmaceutical Market 2008-2013 (US$ million)
  • Pharmaceutical Market
    • Summary of the Taiwanese Pharmaceutical Market in 2008
    • Projected Pharmaceutical Market, 2008-2013
  • Market Environment
  • Government Biotechnology Initiatives
    • Promotion Plan for the Biotechnology Industry
    • Bio-Tech Island Project
    • Biotech and New Pharmaceutical Development Statute
  • Investment
    • Research
    • Development Center for Biotechnology
  • Manufacturing & Research
    • Abnova
      • Agreements
        • Axela Biosensors
    • AbGenomics
      • AbGenomics - R&D Pipeline
    • ADImmune
      • Agreements
    • Empax Pharma
      • Agreements
    • Life Spring BioTech
    • Mycenax Biotech
      • Mycenax - Project Pipeline
    • NatureWise Biotech & Medicals
      • Products
      • R&D
    • PhytoHealth
    • ScinoPharm
      • Financials
    • Synmosa Biopharma
    • TaiGen Biotechnology
      • Agreements
        • P&G Pharmaceuticals
        • Academia Sinica
        • Chang Gung Memorial Hospital
        • BioXell SpA
        • Arena Pharmaceuticals
    • R&D
      • TG-873870
      • Nemonoxacin
    • Financial Data
  • TaiMed Biologics
  • Taiwan Liposome
    • Agreements
      • SRI International
    • Financials
  • TTY Biopharm
    • R&D
    • Agreements
    • TaiGen Biotechnology
    • Taiwan Liposome
    • YM BioSciences
• THAILAND
  • Biotechnology Market Overview
  • Biopharmaceutical Market
    • Thailand - Projected Biopharmaceutical Market 2008-2013 (US$ million)
  • Pharmaceutical Market
    • Summary of the Thai Pharmaceutical Market, 2008
    • Market Projections, 2008-2013
  • Market Environment
    • Compulsory Licensing
  • Government Biotechnology Initiatives
    • TCELS
    • BIOTEC
  • Manufacturing & Research
    • Delphi Health Services
    • Immunitor
      • R&D Pipeline
• APPENDIX - BIBLIOGRAPHY
• APPENDIX - ACRONYMS
• APPENDIX - EXCHANGE RATES

相關商品

Espicom Business Intelligence發行的製藥相關市場調查報告書

疼痛治療藥市場的發展：侵害受容性及神經性疼痛治療藥的開發

Evolution in the Pain Therapy Drugs Market: Nociceptive and Neuropathic Drug Development

價格 : US $ 2265

出版日期 : 2012年01月

世界非專利藥品市場

World Generic Markets

價格 : US $ 1080

出版日期 : 2012年01月

全球醫藥品市場展望

The Outlook for Pharmaceuticals Worldwide

價格 : US $ 17490

出版日期 : 2012年01月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!